Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis.
about
Inflammation and its resolution as determinants of acute coronary syndromes.The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).TLR4 and Insulin Resistance.ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterol.Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discoveryAlpha linolenic acid in maternal diet halts the lipid disarray due to saturated fatty acids in the liver of mice offspring at weaning.Walnut oil increases cholesterol efflux through inhibition of stearoyl CoA desaturase 1 in THP-1 macrophage-derived foam cells.Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liverFatty acid regulation of hepatic lipid metabolism.SCD1 activity in muscle increases triglyceride PUFA content, exercise capacity, and PPARδ expression in miceThe role of stearoyl-CoA desaturase in obesity, insulin resistance, and inflammation.Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: impact of nonalcoholic fatty liver disease.n-3 Fatty acids modulate the mRNA expression of the Nlrp3 inflammasome and Mtor in the liver of rats fed with high-fat or high-fat/fructose diets.Clinical determinants and mortality predictability of stearoyl-CoA desaturase-1 activity indices in dialysis patients.
P2860
Q33834800-EA1E92C9-4242-4476-9712-F665E65E3163Q33864337-747B91CB-C3D5-45C5-BD7E-C33843FDC266Q34097407-584E9F81-5BC8-40D2-A85F-E25E2995141AQ34112680-BE6EF6DA-6484-4D72-AC3F-54D23DF992EFQ34729735-F3B8C847-DBD0-4FDE-9F20-84A5F642740AQ34997512-06354557-620E-48A8-856C-DAB4079DE4C0Q35132830-28A1B124-811E-460B-BC89-6C3977367428Q35232974-073C6F0F-118C-498B-9391-172891080EC8Q35642914-981027F6-9FAA-44C4-B9D7-B8468B6265D2Q35975409-36EEA320-0034-425A-BBB4-41ABE9185C6FQ37163006-39848500-2DC8-42A3-AF59-035EE2557285Q37972672-DB722A3A-2CE6-4389-BC6D-52BC6C7D39CDQ38866019-86842F9B-5207-49DA-BF2E-703D4EB9F49AQ39639230-AFC9B98A-661F-406C-9F8F-CC77769B3A8CQ51317684-81193D2D-379A-4282-B4E3-0E799CFCEC31
P2860
Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combined therapy of dietary fi ...... syndrome and atherosclerosis.
@en
Combined therapy of dietary fi ...... syndrome and atherosclerosis.
@nl
type
label
Combined therapy of dietary fi ...... syndrome and atherosclerosis.
@en
Combined therapy of dietary fi ...... syndrome and atherosclerosis.
@nl
prefLabel
Combined therapy of dietary fi ...... syndrome and atherosclerosis.
@en
Combined therapy of dietary fi ...... syndrome and atherosclerosis.
@nl
P2093
P2860
P1476
Combined therapy of dietary fi ...... syndrome and atherosclerosis.
@en
P2093
Amanda L Brown
Caleb Lord
Chiara Degirolamo
Heather M Alger
J Mark Brown
Janet K Sawyer
Jennifer Madenspacher
John S Parks
Kathryn Kelley
Lawrence L Rudel
P2860
P356
10.1161/ATVBAHA.109.198036
P407
P577
2009-10-15T00:00:00Z